The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study-Reference-Cited by-同舟云学术

The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study

Published:2022 Issue:6 Volume:33 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Lee Yoo-Young¹^ORCID,Kim Soyoun Rachel²^ORCID,Kollara Alexandra³^ORCID,Brown Theodore³⁴^ORCID,May Taymaa²⁴^ORCID

Affiliation:

1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea.

2. Division of Gynecologic Oncology, Princess Margaret Cancer Center, Toronto, ON, Canada.

3. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.

4. Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2022.33.e76

Reference32 articles.

1. Latest research and treatment of advanced-stage epithelial ovarian cancer

2. Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study

3. Impact of radical bowel resection on survival in advanced epithelial ovarian cancer

4. The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients;Frontiers in Oncology;2023-08-16